Cargando…

Use of levosimendan in acute heart failure

As a calcium sensitizer and inodilator that augments cardiac contractility without increasing myocardial oxygen demand or exacerbating ischaemia, levosimendan may be well configured to deliver inotropic support in cases of acute heart failure (AHF). Other factors favouring levosimendan in this setti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harjola, Veli-Pekka, Giannakoulas, George, von Lewinski, Dirk, Matskeplishvili, Simon, Mebazaa, Alexandre, Papp, Zoltan, Schwinger, Robert H G, Pollesello, Piero, Parissis, John T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288642/ https://www.ncbi.nlm.nih.gov/pubmed/30555279 http://dx.doi.org/10.1093/eurheartj/suy039

Ejemplares similares

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
por: Bouchez, S., et al.
Publicado: (2018)

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019)

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)

Levosimendan‐induced venodilation is mediated by opening of potassium channels
por: Burkhoff, Daniel, et al.
Publicado: (2021)

Renal Effects of Levosimendan: A Consensus Report
por: Yilmaz, Mehmet B., et al.
Publicado: (2013)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014)

Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta‐analysis of randomized trials
por: Silvetti, Simona, et al.
Publicado: (2017)

The inodilator levosimendan as a treatment for acute heart failure in various settings
por: Gustafsson, Finn, et al.
Publicado: (2017)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
por: Pollesello, Piero, et al.
Publicado: (2019)

Focused echocardiography and lung ultrasound protocol for guiding treatment in acute heart failure
por: Öhman, Jonas, et al.
Publicado: (2017)

Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan
por: Fedele, Francesco, et al.
Publicado: (2017)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Facing up to the challenges of acute heart failure
por: Pollesello, Piero
Publicado: (2020)

Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study
por: Masarone, Daniele, et al.
Publicado: (2022)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
por: Wechsler, Maximilian, et al.
Publicado: (2022)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

A review of levosimendan in the treatment of heart failure
por: Kasikcioglu, Hulya Akhan, et al.
Publicado: (2006)

Levosimendan in pulmonary hypertension and right heart failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)

Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland
por: Hallinen, Taru, et al.
Publicado: (2023)

In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting
por: Yilmaz, Mehmet Birhan, et al.
Publicado: (2011)

Pre‐hospital management protocols and perceived difficulty in diagnosing acute heart failure
por: Harjola, Pia, et al.
Publicado: (2019)

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
por: Pölzl, Gerhard, et al.
Publicado: (2018)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Differential effects of inotropes and inodilators on renal function in acute cardiac care
por: Zima, Endre, et al.
Publicado: (2020)

Recognizing early signs in the translational phase is essential for drug development in cardiovascular medicine
por: Papp, Zoltán, et al.
Publicado: (2023)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay
por: Grossini, Elena, et al.
Publicado: (2015)

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019)

Efficiency and Safety of Prolonged Levosimendan Infusion in Patients with Acute Heart Failure
por: Aidonidis, Georgios, et al.
Publicado: (2011)

Levosimendan in acute and advanced heart failure: still some chapters to be written
por: Pölzl, Gerhard
Publicado: (2018)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies
por: Glinka, Lidia, et al.
Publicado: (2019)

Heart Failure
por: Giamouzis, Gregory, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i59rdna4agsdmekp9kg1fkuf4u